Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $317.8M | -- | -- | $2.70 | -- |
| 11/05/2025 | Q3 | $275.1M | $252.1M | $1.93 | $2.19 | -$0.27 |
| 08/06/2025 | Q2 | $213.7M | $209.6M | $2.01 | $1.68 | $0.33 |
| 05/07/2025 | Q1 | $166.5M | $193.4M | $1.73 | $1.37 | $0.36 |
| 02/12/2025 | Q4 | $186.2M | $202.6M | $1.63 | $1.48 | $0.15 |
| 11/06/2024 | Q3 | $183.2M | $193.8M | $1.46 | $1.32 | $0.15 |
| 08/07/2024 | Q2 | $171.7M | $174.1M | $1.23 | $1.19 | $0.05 |
| 05/08/2024 | Q1 | $153M | $148.9M | $0.72 | $0.92 | -$0.20 |
| 02/14/2024 | Q4 | $140.3M | $152.7M | $0.96 | $0.76 | $0.19 |
| 11/01/2023 | Q3 | $127.3M | $138.6M | $0.75 | $0.78 | -$0.03 |
| 08/02/2023 | Q2 | -- | $144M | $0.96 | -- | -- |
| 05/03/2023 | Q1 | -- | $170.4M | $0.97 | -- | -- |
| 02/15/2023 | Q4 | -- | $163M | $0.86 | -- | -- |
| 11/02/2022 | Q3 | -- | $131.4M | $0.70 | -- | -- |
| 08/03/2022 | Q2 | -- | $146.4M | $1.08 | -- | -- |
| 05/04/2022 | Q1 | -- | $162.4M | $1.07 | -- | -- |
| 02/17/2022 | Q4 | -- | -- | $1.04 | $0.94 | $0.10 |
| 11/03/2021 | Q3 | -- | -- | $1.07 | -- | -- |
| 08/11/2021 | Q2 | -- | $168M | $1.24 | -- | -- |
| 05/05/2021 | Q1 | -- | $142.6M | $0.82 | -- | -- |
| 02/03/2021 | Q4 | -- | $158.4M | $0.91 | -- | -- |
| 11/04/2020 | Q3 | -- | $146.9M | $1.63 | -- | -- |
| 08/05/2020 | Q2 | -- | $120M | $0.75 | -- | -- |
| 05/06/2020 | Q1 | -- | $136.4M | $0.59 | -- | -- |
| 02/05/2020 | Q4 | -- | $123.6M | $0.63 | -- | -- |
| 11/06/2019 | Q3 | -- | $118.8M | $1.07 | -- | -- |
| 08/07/2019 | Q2 | -- | $115.7M | $0.40 | -- | -- |
| 05/01/2019 | Q1 | -- | $109.8M | $0.44 | -- | -- |
| 02/06/2019 | Q4 | -- | $97.6M | $0.36 | -- | -- |
| 10/31/2018 | Q3 | -- | $100M | $0.23 | -- | -- |
| 08/09/2018 | Q2 | -- | $116.2M | $0.41 | -- | -- |
| 05/03/2018 | Q1 | -- | $116M | -$2.35 | -- | -- |
| 02/08/2018 | Q4 | -- | $114.3M | -$0.23 | -- | -- |
| 11/02/2017 | Q3 | -- | $112.5M | $0.44 | -- | -- |
| 08/10/2017 | Q2 | -- | $108.9M | $0.31 | -- | -- |
| 05/11/2017 | Q1 | -- | $107M | $0.36 | -- | -- |
| 02/02/2017 | Q4 | -- | $107M | $0.43 | -- | -- |
| 11/03/2016 | Q3 | -- | $117.9M | $0.46 | -- | -- |
| 08/11/2016 | Q2 | -- | $94.1M | $0.31 | -- | -- |
| 04/28/2016 | Q1 | -- | $93.5M | -$1.04 | -- | -- |
| 02/04/2016 | Q4 | -- | $98.1M | $0.23 | -- | -- |
Royal Gold, Inc. reported $252.1M worth of top line sales in its most recent quarter.
Royal Gold, Inc. announced earnings per share of $1.93 which represents a miss of analyst forecast a $2.19 per share.
Royal Gold, Inc. reported $185.4M that represents $2.82 per share over the last quarter.
Royal Gold, Inc.'s earnings are forecast to grow from $5.05 per share to $5.07 per share next year representing an increase of 58.54%.
Royal Gold, Inc.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.